Acadian Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.8M | Sell |
161,000
-302,647
| -65% | -$20.2M | 0.01% | 572 |
|
|
2026
Q1 | $29.1M | Sell |
463,647
-41,426
| -8% | -$2.88M | 0.04% | 319 |
|
|
2025
Q4 | $33.5M | Buy |
505,073
+300,140
| +146% | +$19.4M | 0.06% | 261 |
|
|
2025
Q3 | $13.8M | Sell |
204,933
-68,360
| -25% | -$5.41M | 0.02% | 400 |
|
|
2025
Q2 | $23.8M | Buy |
273,293
+84,665
| +45% | +$6.64M | 0.05% | 285 |
|
|
2025
Q1 | $12.9M | Buy |
188,628
+138,335
| +275% | +$11.3M | 0.04% | 288 |
|
|
2024
Q4 | $3.91M | Sell |
50,293
-63,123
| -56% | -$4.67M | 0.01% | 589 |
|
|
2024
Q3 | $7.6M | Buy |
113,416
+88,877
| +362% | +$7.3M | 0.02% | 394 |
|
|
2024
Q2 | $2.78M | Buy |
24,539
+16,531
| +206% | +$2.09M | 0.01% | 670 |
|
|
2024
Q1 | $1.11M | Buy |
8,008
+2,299
| +40% | +$289K | ﹤0.01% | 814 |
|
|
2023
Q4 | $707K | Buy |
5,709
+18
| +0.3% | +$1.84K | ﹤0.01% | 947 |
|
|
2023
Q3 | $530K | Sell |
5,691
-18,573
| -77% | -$2.09M | ﹤0.01% | 990 |
|
|
2023
Q2 | $3.11M | Sell |
24,264
-5,419
| -18% | -$655K | 0.01% | 574 |
|
|
2023
Q1 | $3.44M | Buy |
29,683
+6,956
| +31% | +$779K | 0.02% | 557 |
|
|
2022
Q4 | $2.57M | Buy |
22,727
+22,240
| +4,567% | +$2.44M | 0.01% | 614 |
|
|
2022
Q3 | $39K | Sell |
487
-2,093
| -81% | -$177K | ﹤0.01% | 1527 |
|
|
2022
Q2 | $192K | Buy |
2,580
+1,456
| +130% | +$133K | ﹤0.01% | 1209 |
|
|
2022
Q1 | $143K | Sell |
1,124
-1,068
| -49% | -$117K | ﹤0.01% | 1279 |
|
|
2021
Q4 | $294K | Sell |
2,192
-4
| -0.2% | -$575 | ﹤0.01% | 1147 |
|
|
2021
Q3 | $299K | Sell |
2,196
-3,184
| -59% | -$402K | ﹤0.01% | 1189 |
|
|
2021
Q2 | $574K | Buy |
5,380
+2,788
| +108% | +$268K | ﹤0.01% | 1100 |
|
|
2021
Q1 | $233K | Sell |
2,592
-5,232
| -67% | -$491K | ﹤0.01% | 1446 |
|
|
2020
Q4 | $723K | Sell |
7,824
-3,648
| -32% | -$326K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $1.18M | Buy |
11,472
+2,632
| +30% | +$275K | 0.01% | 844 |
|
|
2020
Q2 | $896K | Sell |
8,840
-163,440
| -95% | -$14.6M | ﹤0.01% | 1003 |
|
|
2020
Q1 | $11.6M | Buy |
172,280
+163,612
| +1,888% | +$10.2M | 0.07% | 229 |
|
|
2019
Q4 | $475K | Buy |
+8,668
| New | +$411K | ﹤0.01% | 1088 |
|
|
2019
Q2 | – | Sell |
-105,500
| Closed | -$3.14M | – | 1869 |
|
|
2019
Q1 | $3.14M | Sell |
105,500
-127,416
| -55% | -$4.48M | 0.01% | 565 |
|
|
2018
Q4 | $6.98M | Buy |
232,916
+136,164
| +141% | +$4.32M | 0.03% | 328 |
|
|
2018
Q3 | $3.46M | Buy |
+96,752
| New | +$3M | 0.01% | 446 |
|
|
2017
Q2 | – | Sell |
-384
| Closed | -$8K | – | 1473 |
|
|
2017
Q1 | $8K | Sell |
384
-416
| -52% | -$8.12K | ﹤0.01% | 1434 |
|
|
2016
Q4 | $12K | Sell |
800
-9,708
| -92% | -$172K | ﹤0.01% | 1395 |
|
|
2016
Q3 | $230K | Buy |
10,508
+9,688
| +1,181% | +$216K | ﹤0.01% | 943 |
|
|
2016
Q2 | $16K | Hold |
820
| – | – | ﹤0.01% | 1150 |
|
|
2016
Q1 | $14K | Sell |
820
-78,632
| -99% | -$1.31M | ﹤0.01% | 1132 |
|
|
2015
Q4 | $1.63M | Buy |
79,452
+78,632
| +9,589% | +$1.64M | 0.01% | 608 |
|
|
2015
Q3 | $18K | Hold |
820
| – | – | ﹤0.01% | 1065 |
|
|
2015
Q2 | $16K | Hold |
820
| – | – | ﹤0.01% | 1103 |
|
|
2015
Q1 | $12K | Hold |
820
| – | – | ﹤0.01% | 1177 |
|
|
2014
Q4 | $12K | Buy |
820
+484
| +144% | +$5.92K | ﹤0.01% | 1102 |
|
|
2014
Q3 | $3K | Buy |
+336
| New | +$3.44K | ﹤0.01% | 1003 |
|
Other funds holding DXCM
VCM
VPM
Acadian Asset Management's DXCM Position: Q2 2026 in Review
Acadian Asset Management reduced its DexCom (DXCM) stake by 65% in Q2 2026, selling an estimated $20.2M and leaving 161,000 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #572.
Acadian Asset Management first reported a position in DXCM in Q3 2014 and has held it in 41 quarters since. The position peaked at $33.5M in Q4 2025. 758 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Acadian Asset Management held 161,000 shares of DexCom worth $10.8M as of Q2 2026.
- Acadian Asset Management sold 302,647 DexCom shares in Q2 2026, an estimated $20.2M.
- DexCom made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #572 holding.
- Acadian Asset Management first reported a position in DexCom in Q3 2014 and has held it in 41 quarters since.
- Acadian Asset Management's DexCom position peaked at $33.5M in Q4 2025.
- 758 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.